Status:

UNKNOWN

Dengue Vaccine Hesitancy and Acceptance in Endemic Regions of Argentina: Impact of Communication Strategies

Lead Sponsor:

Fundacion GESICA

Conditions:

Dengue

Eligibility:

All Genders

18+ years

Brief Summary

Among all arboviruses, Dengue (DEN) is the vector borne disease with the highest burden worldwide. Around 390 million infections per year are estimated, of which around 96 million are clinically appar...

Eligibility Criteria

Inclusion

  • People who express willingness to participate and who are residents of communes with a high burden of Dengue disease.

Exclusion

  • Persons who do not give informed consent.

Key Trial Info

Start Date :

April 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 1 2023

Estimated Enrollment :

1500 Patients enrolled

Trial Details

Trial ID

NCT05213364

Start Date

April 1 2022

End Date

November 1 2023

Last Update

January 28 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.